Blood pressure, systolic and diastolic, and cardiovascular risks: US population data

Archives of Internal Medicine

Volumn 153, Issue 5, 1993, Pages 598-615

  Stamler, Jeremiah ^a   Stamler, Rose ^a   Neaton, James D ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY INJURY; LIFE EXPECTANCY; MALE; MORBIDITY; MORTALITY; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; STROKE; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; UNITED STATES;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIASTOLE; FEMALE; HUMAN; HYPERTENSION; MALE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SYSTOLE; UNITED STATES;

EID: 0027469656     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.153.5.598     Document Type: Article

References (77)

1. Stamler J. High blood pressure in the United States: an overview of the problem and the challenge. In: National Conference on High Blood Pressure Education: Report of Proceedings. Rockville, Md: US Dept of Health, Education and Welfare, Public Health Service, National Institutes of Health; 1973:11-66. DHEW publication (NIH) 73-486.
2. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 1978:31:201-306.
3. Inter-Society Commission for Heart Disease Resources, Atherosclerosis Study Group and Epidemiology Study Group. Primary prevention of the atherosclerotic diseases. Circulation. 1970; 42:A55-A95.
4. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed for five years. Am Heart J. 1984;108:759-769.
5. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828
6. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension. 1989;13:2-12.
7. Stamler J. Blood pressure and high blood pressure: aspects of risk. Hypertension. 1991;18 (suppl 1):1-97-1-107.
8. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men: Multiple Risk Factor Intervention Trial (MRFIT). Arch Intern Med. 1992;152:56-64.
9. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. Fifth Report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993; 153:154-183.
10. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988:77:504-514.
11. Working Group on Management of Patients With Hypertension and High Blood Cholesterol. National Education Programs Working Group Report on the Management of Patients With Hypertension and High Blood Cholesterol. Ann Intern Med. 1991;114:224-237.
12. Stamler R. The primary prevention of hypertension and the population blood pressures problem. In: Marmot M, Elliott P, eds. Coronary Heart Disease Epidemiology: From Aetiology to Public Health. New York, NY: Oxford University Press; 1992:415-434.
13. Xian ZX. Consistency of the Association of Blood Pressure. Serum Cholesterol and Cigarette Smoking With Coronary Heart Disease Death Among 20 Screening Sites for the Multiple Risk Factor Intervention Trial. Minneapolis, Minn: University of Minnesota; 1991:1-37.
14. Stamler J. Established major coronary risk factors. In: Marmot M, Elliott P, eds. Coronary Heart Disease Epidemiology: From Aetiology to Public Health. New York, NY: Oxford University Press; 1992:35-66.
15. Stamler J, Dyer A, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all causes mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiologia. In press.
16. Stamler J. Lectures on Preventive Cardiology. New York, NY: Grune & Stratton; 1967.
17. Keil JE, Gazes PC, Loadholt CB, et al. Coronary heart disease mortality and its predictors among women in Charleston, South Carolina. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987:90-98.
18. Pell S, D'Alonzo CA. Acute myocardial infarction in a large industrial population: report of a 6-year study of 1,356 cases. JAMA. 1963;185:117-124.
19. Beaglehole R, Heiss G, Tyroler HA, Cassel JC, Hames CG. Prevalence and incidence data in the assessment of the risk of coronary heart disease. Am J Epidemiol. 1975;102:55-62.
20. Wilson PW, Anderson KM, Castelli WP. Twelveyear incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham Offspring Study. Am J Med. 1991;90:11-16.
21. Reed DM, MacLean CJ, Hayashi T. Predictors of atherosclerosis in the Honolulu Heart Program, I: biologic, dietary, and lifestyle characteristics. Am J Epidemiol. 1987;126:214-225.
22. Yano K, MacLean CJ, Reed DM, et al. A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Am J Epidemiol. 1988;127:476-487.
23. Kagan A, Yano K, Reed DM, MacLean CJ. Predictors of sudden cardiac death among Hawaiian-Japanese men. Am J Epidemiol. 1989;130:268-277.
24. Reed D, MacLean C. The nineteen-year trends in CHD in the Honolulu Heart Program. Int J Epidemiol. 1989;18:S82-S87.
25. Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis. 1987;40:775-784.
26. Borhani NO, Hechter HH, Breslow L. Report of a ten-year follow-up study of the San Francisco Longshoremen: mortality from coronary heart disease and from all causes. J Chronic Dis. 1963; 16:1251-1266.
27. Paffenbarger RS, Gima AL, Laughlin E, Black RA. Characteristics of longshoremen related to fatal coronary heart disease and stroke Am J Public Health. 1971;61:1362-1370.
28. Society of Actuaries. Build and Blood Pressure Study, 1959. Chicago, III: Society of Actuaries; 1959.
29. Society of Actuaries and Association of Life Insurance Medical Directors of America. Blood Pressure Study, 1979. Chicago, III: Society of Actuaries and Association of Life Insurance Medical Directors of America: 1980:1-359.
30. Rosenman RH, Brand RJ, Jenkins D. Friedman M, Straus R, Wurm M. Coronary heart disease in the Western Collaborative Group Study, final follow-up experience of 8.5 years. JAMA 1975; 233:872-877.
31. Ragland DR, Brand RJ. Coronary heart disease mortality in the Western Collaborative Group Study: follow-up experience of 22 years. Am J Epidemiol. 1988;127:462-475.
32. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978;108:161-175,
33. Guzik HJ, Ooi WL, Frishman WH. Greenberg S, Aronson MK. Hypertension: cardiovascular implications in a cohort of old old. J Am Geriatr Soc. 1992;40:348-353.
34. Kannel WB, Wolf PA, Garrison RJ, eds. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements Framingham Heart Study, 30-Year Follow-up Bethesda, Md: National Institutes of Health; 1987. Publication NIH 87-2703.
35. Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 1990;263:393-396
36. Leaverton PE, Havlik RJ, Ingster-Moore LM, La Croix AZ, Cornoni-Huntley JC. Coronary heart disease and hypertension. In: Cornoni-Huntley JC, Huntley RR, Feldman JJ, eds. Health Status and Well-being of the Elderly: National Health and Nutrition Examination Survey I - Epidemiologie Follow-up Study. New York, NY: Oxford University Press; 1990:53-70.
37. Garland C, Barrert-Connor E, Suarez L, Criqui MH. Isolated systolic hypertension and mortality after age 60 years: a prospective population-based study. Am J Epidemiol. 1983;118:365-376.
38. Probstfield JL, Furberg CD. Systolic hypertension in the elderly: controlled or uncontrolled. in: Frohlich ED, ed. Preventive Aspects of Coronary Heart Disease. Philadelphia, Pa: FA Davis Co Publishers; 1990:65-84.
39. Colandrea MA, Friedman GD, Nichaman MZ, Lynd CN. Systolic hypertension in the elderly: an epidemiologic assessment. Circulation. 1970;41: 239-245.
40. Shekelle RB, Ostfeld AM, Klawans HL. Hypertension and risk of stroke in an elderly population. Stroke. 1974;5:71-75.
41. Dyer AR, Stamler J, Shekelle RB, Schoenberger JA, Farinaro E. Hypertension in the elderly. Med Clin North Am. 1977;61:513-529.
42. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265:3255-3264.
43. Wingard DL, Cohn BA. Coronary heart disease mortality among women in Alameda County, 1965 io 1973. In: Eaker ED, Packard B, Wenger IM, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987: 99-105.
44. Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Coronary heart disease risk factors in women: the Nurses' Health Study experience. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987: 112-116.
45. Higgins M, Keller JB, Ostrander LD. Risk factors for coronary heart disease in women: Tecumseh Community Health Study, 1959 to 1980. In: Eaker ED, Packard B, Wenger N, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987:83-89.
46. Krueger DE, Ellenberg SS, Bloom S, et al. Risk factors for fatal heart attack in young women. Am J Epidemiol. 1981;113:357-370.
47. Rosenberg L, Miller DR, Kaufman DW, Helmrich SP, Van De Carr S, Stolley PD, Shapiro S. Myocardial infarction in women under 50 years of age. JAMA. 1983;250:2801-2806.
48. Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA. eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987.
49. Barrett-Connor E, Khaw KT, Wingard DL. A ten year prospective study of coronary heart disease mortality among Rancho Bernardo women. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987:117-121.
50. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
51. White LR, Losonczy KG, Wolf PA. Cerebrovascular disease. In: Cornoni-Huntley JC, Huntley RR, Feldman JJ, eds. Health Status and Wellbeing of the Elderly: National Health and Nutrition Examination Survey I - Epidemiologie Follow-up Study. New York, NY: Oxford University Press; 1990:115-135.
52. Liao YL, Liu KA, Dyer A, et al. Major and minor electrocardiographic abnormalities and risk of death from coronary heart disease, cardiovascular diseases and all causes in men and women. J Am Coll Cardiol. 1988;12:1494-1500.
53. Levy O, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
54. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
55. Stamler R, Stamler J, Schoenberger JA, et al. Relationship of glucose tolerance to prevalence of ECG abnormalities and to 5-year mortality from cardiovascular disease: findings of the Chicago Heart Association Detection Project in Industry. J Chronic Dis. 1979;32:817-828.
56. Stamler R, Stamler J, Lindberg HA, et al. Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chronic Dis. 1979;32:805-815.
57. Prineas RJ, Castle CH, Curb JD, Harrist R, Lewin A, Stamler J. Hypertension Detection and Follow-up Program: baseline electrocardiographic characteristics of the hypertensive participants. Hypertension. 1983;5:160-189.
58. Blaufox MD, Borhani MO, Curb JD, et al. Results and implications of the Hypertension Detection and Follow-up Program. Prog Cardiovasc Dis. 1986;29:1-124.
59. Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ. All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Dis. 1986;29:29-54.
60. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension. 1985;7:105-112.
61. MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1989;63: 202-210.
62. Whelton PK, Klag MJ. Hypertension as a risk factor for renal diseases: a review of clinical and epidemiological evidence. Hypertension. 1989; 13(suppl 1):1-19-1-27.
63. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension and chronic renal failure. Arch Intern Med. 1991;151:1280-1287.
64. Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from MRFIT and TOMHS. Am J Kidney Dis. In press.
65. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension. 1989:13(suppl 1):1-80-1-93.
66. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992:268:3085-3091.
67. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol. 1989; 129:1110-1119.
68. Khaw KT, Barrett-Connor E. Family history of heart attack: a modifiable risk factor? Circulation. 1986; 74:239-244.
69. Bush TL, Criqui MH, Cowan LD, et al. Cardiovascular disease mortality in women: results from the Lipid Research Clinics Follow-up Study. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women: Proceedings of an NIH Workshop. New York, NY: Haymarket Doyma Inc; 1987.
70. Cornoni-Huntley J, LaCroix AZ, Havlik BJ. Race and sex differentials in the impact of hypertension in the United States - the National Health and Nutrition Examination Survey, I: Epidemiologic Follow-up Study. Arch Intern Med. 1989; 149:780-788.
71. Whelton PK, Adams-Campbell LL, Appel LJ, et al. Working group report on the primary prevention of hypertension. Arch Intern Med. In press.
72. National Center for Health Statistics. Vital Statistics of the United States. 1989, Vol II: Mortality, Part A. Section 6, Life Tables. Washington, DC: Public Health Service; 1992:11.
73. National Center for Health Statistics. Leading components of upturn in mortality for men: United States 1952-1967. Vital Health Stat 20. 1981;No. 11.
74. Stamler J, Shekelle RB. Lower dietary cholesterol and saturated fat intake, lower serum cholesterol, and expected effects on coronary risk and on longevity. Lipid Rev. 1989;3:89-96.
75. Stamler J, Shekelle RB. Reduction of dietary cholesterol, saturated fat intakes and serum cholesterol: expected effects on coronary risk and on longevity. In: Lewis B, Assmann G, eds. The Social and Economic Contexts of Coronary Prevention. London, England: Current Medical Literature; 1990:3-10.
76. US Bureau of the Census. Statistical Abstract of the United States. Washington, DC: US Bureau of the Census; 1990:12.
77. Stamler J. Salt and blood pressure. Proc N Y Acad Sci. In press.